Artificial Intelligence (AI) in Breast Imaging Market Global

Source Domain: www.openpr.com

Market Growth Projection: The Global Artificial Intelligence (AI) in Breast Imaging Market is projected to reach over USD 7,184.27 million by 2035, with a significant Compound Annual Growth Rate (CAGR) of 28.5%.
Technological Advancements: The adoption of AI in breast imaging is driven by advancements from digital imaging modalities such as digital mammography, ultrasound, and MRI, facilitating more precise diagnoses and informed clinical decision-making.
Regulatory Support: Regulatory bodies like the U.S. Food and Drug Administration (FDA) have established guidelines for AI-based medical devices in healthcare, promoting transparency, innovation, and patient safety.
Regional Dominance: North America is expected to dominate the global AI in breast imaging market due to a high incidence of breast cancer, advanced healthcare infrastructure, significant R&D investments, and supportive regulatory frameworks.
Drivers and Challenges: Key factors driving the market include the rising prevalence of breast cancer, increasing healthcare costs, and technological progress. Challenges involve high costs, data privacy/security issues, limited interoperability, and regulatory complexities.
Recent Developments: Notable collaboration in March 2022 between The National Oncology Centre of Singapore (NCCS) and GE Healthcare aims to boost individualized cancer treatment using AI and language processing technologies.

You may have missed